Today: 9 June 2026
POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears
21 April 2026
1 min read

POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears

NEW YORK, April 21, 2026, 10:36 EDT

Shares of POET Technologies surged 20% Tuesday, building on Monday’s 18% rally. Investors piled back into the optical-chip company after it took steps to calm U.S. shareholder tax worries that weighed on the stock last week. By 10:21 a.m. ET, the Nasdaq stock was up $1.75 to $10.34, after hitting an intraday peak of $11.07. Volume reached nearly 32.9 million shares.

POET shares saw 44.6 million change hands Monday—roughly 324% more than their three-month average, Yahoo Finance data shows. The spike in volume puts the stock firmly in the AI-and-connectivity trade, with tech getting renewed interest from Wall Street even as geopolitical tensions linger.

Wolfpack Research kicked things off with a short call on POET on April 14. Hours later, POET responded: U.S. shareholders would get the info needed for a qualified electing fund (QEF) election, and the board had signed off on a move to re-domicile in the U.S. PFIC—passive foreign investment company—is a U.S. tax classification that can spell trouble for certain investors’ tax situations.

Chief Financial Officer Thomas Mika stated the company doesn’t expect to be considered a PFIC in 2026, adding that, if necessary, it’s ready to submit the redomiciling plan to a shareholder vote on June 26.

POET’s rally is taking off well ahead of the company hitting scale. In the fourth quarter, it posted $341,202 in non-recurring engineering and product revenue, along with a net loss that reached $42.7 million. Still, Chief Executive Suresh Venkatesan called the period a “decisive transition from development to execution.” GlobeNewswire

POET reported on March 31 that its cash reserves stood at $430 million, after locking down over $225 million in funding in the fourth quarter and another $150 million in January. The company also landed a production order topping $5 million for its Infinity optical engines—those are built on POET’s Optical Interposer, a platform meant to integrate electronic and optical parts all on one chip.

The company’s trying to tap into AI data-center growth through new partnerships. POET and Taiwan’s LITEON agreed in March to co-develop optical modules for AI use, with initial prototypes due late 2026 and full-scale output eyed for 2027.

POET isn’t the only player chasing photonics. Marvell, for example, has moved further into the space with its Celestial AI partnership. Credo, just last week, struck a deal to acquire DustPhotonics, aiming to bulk up its silicon-photonics and optical-connectivity lineup for AI data centers.

Breadth lent a hand Tuesday, with the Nasdaq ticking up roughly 0.14% in the morning. “Strong earnings were ‘overpowering the narrative’” behind the market’s latest whipsaws, Thomas Hayes, Great Hill Capital’s chairman, told Reuters. Reuters

Still, risks linger. Mass production with LITEON doesn’t hit until 2027. The U.S. redomicile could hinge on a shareholder vote. And as of April 18, analysts on Simply Wall St were looking for an average 12-month target of $8.20—a number sitting under Tuesday’s price.

Stock Market Today

  • Proxy Adviser Supports Nanoco Group's Plan to Delist from LSE
    June 9, 2026, 9:17 AM EDT. Nanoco Group PLC, a nanotechnology firm, announced that independent proxy adviser Glass Lewis has recommended shareholders approve the company's resolution to delist from the London Stock Exchange (LSE). The move signals a significant shift for Nanoco, potentially changing its trading and regulatory environment. Shareholder approval for such a resolution typically permits a company to withdraw its shares from public exchange trading, often to pursue private ownership or alternative funding routes. This development follows Nanoco's strategic review and may impact investor access and share liquidity. The recommendation by Glass Lewis adds weight to the proposal ahead of the upcoming shareholder vote.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Amazon to Invest Up to $25 Billion More in Anthropic as Claude Maker Commits $100 Billion to AWS
Previous Story

Amazon to Invest Up to $25 Billion More in Anthropic as Claude Maker Commits $100 Billion to AWS

AT&T and Citi Refresh Points Plus Card With New Rewards, Bill Discounts and No Foreign Fees
Next Story

AT&T and Citi Refresh Points Plus Card With New Rewards, Bill Discounts and No Foreign Fees

Go toTop